2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by ABBATE, M. Articles by REMUZZI, G. Search for Related Content PubMed PubMed Citation Articles by ABBATE, M. Articles by REMUZZI, G.

Antiproteinuric Therapy while Preventing the Abnormal Protein Traffic in Proximal Tubule Abrogates Protein- and Complement-Dependent Interstitial Inflammation in Experimental Renal Disease

MAURO ABBATE^*, CARLA ZOJA^*, DANIELA ROTTOLI^*, DANIELA CORNA^*, NORBERTO PERICO^*,, TULLIO BERTANI^*, and GIUSEPPE REMUZZI^*,

^* Mario Negri Institute for Pharmacological Research, Bergamo, Italy.
Unit of Nephrology and Dialysis, Azienda Ospedaliera, Ospedali Riuniti di Bergamo, Bergamo, Italy.

Correspondence to Dr. Mauro Abbate, "Mario Negri" Institute for Pharmacological Research, Via Gavazzeni 11, 24125 Bergamo, Italy. Phone: + 39 (35) 319.888; Fax: + 39 (35) 319.331; E-mail: abbate{at}irfmn.mnegri.it

Abstract. In proteinuric glomerulopathies, the excess traffic of proteins into the renal tubule is a candidate trigger of interstitial inflammatory and immune events leading to progressive injury, and a key target for the renoprotective action of antiproteinuric drugs. Among proteins trafficked to the proximal tubule, the third component of complement (C3) can be activated locally and contribute to inflammation at sites of protein reabsorption. Experiments were performed in rats with renal mass reduction (RMR, 5/6 nephrectomy) with the following aims: (1) to study Ig (IgG) and complement deposition in proximal tubules, and interstitial macrophage infiltration and MHC class II expression at intervals after surgery by double immunofluorescence analysis; (2) to assess whether lisinopril (angiotensin-converting enzyme inhibitor [ACEi], 25 mg/L in the drinking water, from either day 1 or day 7) limited IgG and C3 accumulation and interstitial inflammation at day 30. In 7-d remnant kidneys, intracellular staining for both IgG and C3 was detectable in proximal tubules in focal areas; C3 was restricted to IgG-positive tubular cells, and there were no interstitial ED-1 macrophage and MHC II-positive cellular infiltrates. In 14-d and 30-d remnant kidneys, proximal tubular IgG and C3 staining was associated with the appearance of interstitial infiltrates that preferentially localized to areas of tubules positive for both proteins. RMR rats given ACEi had no or limited increases in levels of urinary protein excretion, tubular IgG, and C3 reactivity, and interstitial cellular infiltrates in kidneys at 30 d, even when ACEi was started from day 7 after surgery. These findings document that (1) in RMR, IgG and C3 accumulation in proximal tubular cells is followed by leukocyte infiltration and MHC II overexpression in the adjacent interstitium; (2) ACEi while preventing proteinuria limits both tubular accumulation of IgG and C3 and interstitial inflammation. The data suggest that ACE inhibition can be renoprotective by limiting the early abnormal protein traffic in proximal tubule and consequent deleterious effects of excess protein reabsorption, including the accumulation and local activation of complement as well as the induction of chemokines and endothelin genes known to promote interstitial inflammation and fibrosis.

This article has been cited by other articles:

				M. Krendel, S. V. Kim, T. Willinger, T. Wang, M. Kashgarian, R. A. Flavell, and M. S. Mooseker Disruption of Myosin 1e Promotes Podocyte Injury J. Am. Soc. Nephrol., January 1, 2009; 20(1): 86 - 94. [Abstract] [Full Text] [PDF]

				S. Zheng, E. C. Carlson, L. Yang, P. M. Kralik, Y. Huang, and P. N. Epstein Podocyte-Specific Overexpression of the Antioxidant Metallothionein Reduces Diabetic Nephropathy J. Am. Soc. Nephrol., November 1, 2008; 19(11): 2077 - 2085. [Abstract] [Full Text] [PDF]

				M. Abbate, C. Zoja, D. Corna, D. Rottoli, C. Zanchi, N. Azzollini, S. Tomasoni, S. Berlingeri, M. Noris, M. Morigi, et al. Complement-Mediated Dysfunction of Glomerular Filtration Barrier Accelerates Progressive Renal Injury J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1158 - 1167. [Abstract] [Full Text] [PDF]

				D. Bolignano, G. Coppolino, S. Campo, C. Aloisi, G. Nicocia, N. Frisina, and M. Buemi Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients Nephrol. Dial. Transplant., January 1, 2008; 23(1): 414 - 416. [Full Text] [PDF]

				M. Abbate, C. Zoja, and G. Remuzzi How Does Proteinuria Cause Progressive Renal Damage? J. Am. Soc. Nephrol., November 1, 2006; 17(11): 2974 - 2984. [Abstract] [Full Text] [PDF]

				M. Nangaku A Crry for polar shedding Nephrol. Dial. Transplant., July 1, 2006; 21(7): 1773 - 1775. [Full Text] [PDF]

				P. Ruggenenti, C. Chiurchiu, M. Abbate, A. Perna, P. Cravedi, M. Bontempelli, and G. Remuzzi Rituximab for Idiopathic Membranous Nephropathy: Who Can Benefit? Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 738 - 748. [Abstract] [Full Text] [PDF]

				V Teplitsky, Y Shoenfeld, and A Tanay The renin-angiotensin system in lupus: physiology, genes and practice, in animals and humans Lupus, June 1, 2006; 15(6): 319 - 325. [Abstract] [PDF]

				P. M. Hall Prevention of Progression in Diabetic Nephropathy Diabetes Spectr, January 1, 2006; 19(1): 18 - 24. [Abstract] [Full Text] [PDF]

				E. Shagdarsuren, M. Wellner, J.-H. Braesen, J.-K. Park, A. Fiebeler, N. Henke, R. Dechend, P. Gratze, F. C. Luft, and D. N. Muller Complement Activation in Angiotensin II-Induced Organ Damage Circ. Res., September 30, 2005; 97(7): 716 - 724. [Abstract] [Full Text] [PDF]

				G. Castellano, V. Cappiello, N. Fiore, P. Pontrelli, L. Gesualdo, F. P. Schena, and V. Montinaro CD40 Ligand Increases Complement C3 Secretion by Proximal Tubular Epithelial Cells J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2003 - 2011. [Abstract] [Full Text] [PDF]

				C. Zoja, M. Morigi, and G. Remuzzi Proteinuria and Phenotypic Change of Proximal Tubular Cells J. Am. Soc. Nephrol., June 1, 2003; 14(90001): S36 - 41. [Full Text] [PDF]

				G. D Laverman, D. de Zeeuw, and G. Navis Between-patient differences in the renal response to renin-angiotensin system intervention: clue to optimising renoprotective therapy? Journal of Renin-Angiotensin-Aldosterone System, December 1, 2002; 3(4): 205 - 213. [Abstract] [PDF]

				C. Zoja, D. Corna, D. Camozzi, D. Cattaneo, D. Rottoli, C. Batani, C. Zanchi, M. Abbate, and G. Remuzzi How To Fully Protect the Kidney in a Severe Model of Progressive Nephropathy: A Multidrug Approach J. Am. Soc. Nephrol., December 1, 2002; 13(12): 2898 - 2908. [Abstract] [Full Text] [PDF]

				M. Abbate, C. Zoja, M. Morigi, D. Rottoli, S. Angioletti, S. Tomasoni, C. Zanchi, L. Longaretti, R. Donadelli, and G. Remuzzi Transforming Growth Factor-{beta}1 Is Up-Regulated by Podocytes in Response to Excess Intraglomerular Passage of Proteins: A Central Pathway in Progressive Glomerulosclerosis Am. J. Pathol., December 1, 2002; 161(6): 2179 - 2193. [Abstract] [Full Text] [PDF]

				R. C. Campbell, P. Ruggenenti, and G. Remuzzi Halting the Progression of Chronic Nephropathy J. Am. Soc. Nephrol., November 1, 2002; 13(90003): S190 - 195. [Abstract] [Full Text]

				D. Harding, P. B. Baines, D. Brull, V. Vassiliou, I. Ellis, A. Hart, A. P. J. Thomson, S. E. Humphries, and H. E. Montgomery Severity of Meningococcal Disease in Children and the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism Am. J. Respir. Crit. Care Med., April 15, 2002; 165(8): 1103 - 1106. [Abstract] [Full Text] [PDF]

				M. Nangaku, J. Pippin, and W. G. Couser C6 Mediates Chronic Progression of Tubulointerstitial Damage in Rats with Remnant Kidneys J. Am. Soc. Nephrol., April 1, 2002; 13(4): 928 - 936. [Abstract] [Full Text] [PDF]

				C.-M. Yu, G. L. Tipoe, K. Wing-Hon Lai, and C.-P. Lau Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1207 - 1215. [Abstract] [Full Text] [PDF]

				W. KRIZ, I. HARTMANN, H. HOSSER, B. HÄHNEL, B. KRÄNZLIN, A. P. PROVOOST, and N. GRETZ Tracer Studies in the Rat Demonstrate Misdirected Filtration and Peritubular Filtrate Spreading in Nephrons with Segmental Glomerulosclerosis J. Am. Soc. Nephrol., March 1, 2001; 12(3): 496 - 506. [Abstract] [Full Text]

				D. N. Muller, E. M. A. Mervaala, F. Schmidt, J.-K. Park, R. Dechend, E. Genersch, V. Breu, B.-M. Loffler, D. Ganten, W. Schneider, et al. Effect of Bosentan on NF-{kappa}B, Inflammation, and Tissue Factor in Angiotensin II-Induced End-Organ Damage Hypertension, August 1, 2000; 36(2): 282 - 290. [Abstract] [Full Text] [PDF]

				Y. MORITA, H. IKEGUCHI, J. NAKAMURA, N. HOTTA, Y. YUZAWA, and S. MATSUO Complement Activation Products in the Urine from Proteinuric Patients J. Am. Soc. Nephrol., April 1, 2000; 11(4): 700 - 707. [Abstract] [Full Text] [PDF]

				D. N. Muller, R. Dechend, E. M. A. Mervaala, J.-K. Park, F. Schmidt, A. Fiebeler, J. Theuer, V. Breu, D. Ganten, H. Haller, et al. NF-{kappa}B Inhibition Ameliorates Angiotensin II-Induced Inflammatory Damage in Rats Hypertension, January 1, 2000; 35(1): 193 - 201. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673